Reuters logo
BRIEF-Novan says ‍agreed to business structure to enable development of SB204 via 3rd party financing and execution
November 7, 2017 / 1:18 PM / in 12 days

BRIEF-Novan says ‍agreed to business structure to enable development of SB204 via 3rd party financing and execution

Nov 7 (Reuters) - Novan Inc:

* Novan Inc -‍agreed to business structure to enable development of SB204 via 3rd party financing, 3rd party execution of additional Phase 3 pivotal trial​

* Novan Inc - ‍proposed Phase 3 trial would be executed by third party’s dermatology drug development team​

* Novan Inc - a ‍new entity established by third party to provide capital to fund, expertise to execute additional Phase 3 pivotal trial for sb204​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below